Loading…

Loading grant details…

Active HORIZON European Commission

Imminent Disease Prediction and Prevention at the Environment Host Interface

€6.22M EUR

Funder European Commission
Recipient Organization Charite - Universitaetsmedizin Berlin
Country Germany
Start Date Jan 01, 2023
End Date Dec 31, 2026
Duration 1,460 days
Number of Grantees 13
Roles Participant; Associated Partner; Coordinator; Third Party
Data Source European Commission
Grant ID 101095540
Grant Description

IMMEDIATE aims to investigate and explore the diet-microbiome-immunometabolism-axis as a sensor for health-to-disease transition and evaluate strategies to maintain an individuals well-being. Chronic inflammation is the major root of most diseases.

Understanding of this process preceding organ dysfunction or damage and identification of biomarkers in the pre-symptomatic stage and risk but also resilience factors of health-to-disease transition will enable targeted and personalized interventions to prevent irreversible organ damage.

Metabolites of gut microbiota are key messengers between diet, microbiota and host, maintaining the balance of pro- and anti-inflammation.

Our study takes advantage of cutting-edge omics technologies available within the IMMEDIATE consortium in conjunction with available clinical data and biospecimens from ongoing observational studies, enrolling healthy subjects and individuals in the pre-disease stage but with largely distinct environmental and dietary modulators, including a cohort of kidney transplant recipients in whom renal function has been reset to baseline.

The identification of clinical and omics-derived biomarkers will by employing AI algorithms - yield a personalized risk / resilience score of chronic inflammation and thus a better prediction of an individuals risk of transition towards disease.

A proof-of-concept intervention study with the anti-inflammatory microbe Akkermansia muciniphila will be conducted to test whether deflections of the microbiome-metabolite-immune axis can be reverted on the biomarker level but also with respect to clinical outcomes and overall well-being.

Mobile apps developed by the IMMEDIATE consortium in collaboration with patient organizations tracking numerous lifestyle-related measures and providing guidance and feedback on these aspects will empower individuals to adopt and integrate these knowledge-based health interventions into their own lives, hereby self-managing their own health.

All Grantees

The Akkermansia Company; Zadig Srl; Imperial College of Science Technology and Medicine; Weizmann Institute of Science; Eurice European Research and Project Office Gmbh; Max Delbrueck Centrum Fuer Molekulare Medizin in Der Helmholtz-Gemeinschaft (Mdc); Pomorski Uniwersytet Medyczny W Szczecinie; Universitaetsklinikum Essen; Charite - Universitaetsmedizin Berlin; Research and Innovation Services Doo Za Usluge; Universitatsklinikum Erlangen; Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa; Bundesverband Niere E.V.

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant